Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247585 · ClinicalTrials.gov registry record · Phase 2
Hangover, Congeners, Sleep and Occupational Performance
A Phase 2 study of Sleep and Neurobehavioral Manifestations, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00247585: Completed Phase 2 study of Sleep and Neurobehavioral Manifestations, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
NCT00247585 is a Phase 2 study of Sleep and Neurobehavioral Manifestations that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 140 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00247585, a Phase 2 study of Sleep and Neurobehavioral Manifestations, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol, alcohol withdrawal effects, and non-ethanol effects, such as congeners, or family history of alcohol problems. The investigators will test the following hypotheses: 1. relative to placebo, heavy drinking will degrade next-day performance, and this relationship will be mediated in full or in part by quality of sleep; 2. a high congener alcoholic beverage will affect performance to a greater degree than a low congener beverage and this relationship will be mediated by severity of hangover symptoms.
Conditions Studied
Interventions
- DRUG Ethanol (Bourbon or Vodka)
Study Locations (1)
Massachusetts
- General Clinical Research Center, Boston University School of Public Health/Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-06 |
| Phase | Phase 2 |
What the finished NCT00247585 record still lists
NCT00247585 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Ethanol (Bourbon or Vodka) is the first listed.
NCT00247585 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00247585 about?
NCT00247585 is a clinical study titled "Hangover, Congeners, Sleep and Occupational Performance". The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alco...
What is the current status of trial NCT00247585?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2003-09. Estimated completion is 2006-06.
What conditions does trial NCT00247585 study?
This clinical trial studies the following conditions: Sleep, Neurobehavioral Manifestations.
What interventions are being tested in trial NCT00247585?
The interventions under investigation include: Ethanol (Bourbon or Vodka) (DRUG).
Who is sponsoring clinical trial NCT00247585?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00247585 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00247585's enrollment target sits among peer trials
140 43rd of 151 higher than 108 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Sleep Trial to Prevent Alzheimer's Disease
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia